Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | TARDBP | Q13148 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.58 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8521624 | 1.00 | HSD17B10 (0.58) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL29249729 | 0.98 | HSD17B10 (0.56) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL29249658 | 0.98 | HSD17B10 (0.56) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL16053552 | 0.96 | HSD17B10 (0.54) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL29263924 | 0.85 | HSD17B10 (0.67) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL19160682 | 0.80 | HSD17B10 (0.53) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL8516674 | 0.79 | CA12 (0.62) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL16144543 | 0.78 | HSD17B10 (0.51) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL17612125 | 0.78 | HSD17B10 (0.51) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL15182687 | 0.77 | HSD17B10 (0.54) | HSD17B10KMT2ATARDBPCYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621537-B1 | PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH | ELFETIN COSMETICS AG (CH) | 2015-02-25 | — | — | EP | claimed |
| US-20130209551-A1 | PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH | ELFETIN COSMETICS AG (CH) | 2013-08-15 | — | — | US | claimed |
| US-20090285888-A1 | DERIVATIVES OF DIHYDROXYPHENYLALANINE | ELLNEUROXX LTD. (DE) | 2009-11-19 | — | — | US | claimed |
| CN-101208326-A | Derivate von dihydroxyphenylalanin | ELLNEUROXX LTD (DE) | 2008-06-25 | — | — | CN | claimed |
| EP-4282411-A1 | LIPOYL-GLU-ALA FOR THE TREATMENT OF NEURODEGENERATIVE DAMAGE CAUSED BY TRAUMATIC BRAIN INJURY | Ischemix LLC (US) | 2023-11-29 | — | — | EP | disclosed |
| EP-2804862-B1 | METHODS OF MAKING AND USING NANOSTRUCTURES | UNIV MINNESOTA (US) | 2019-07-17 | — | — | EP | disclosed |
| US-10239906-B2 | Apparatus and method for obtaining glycoglycerolipids and glycosphingolipids from lipid phases | NANOSCIENCE FOR LIFE GMBH & COKG (DE) | 2019-03-26 | — | — | US | disclosed |
| EP-3152219-B1 | METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPOID PHASES | NANOSCIENCE FOR LIFE GMBH & CO KG (DE) | 2019-01-09 | — | — | EP | disclosed |
| WO-2018053706-A1 | COMPOSITION COMPRISING PAEONIFLORIN OR ALBIFLORIN ANALOGUE, METHOD OF PREPARATION THEREOF | L'OREAL (FR) | 2018-03-29 | — | — | WO | disclosed |
| EP-2640423-B1 | LIPOYL COMPOUNDS AND THEIR USE FOR TREATING ISCHEMIC INJURY | ISCHEMIX LLC (US) | 2017-07-26 | — | — | EP | disclosed |
| US-20170121360-A1 | APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES | GEA WESTFALIA SEPARATOR GROUP GMBH (DE) | 2017-05-04 | — | — | US | disclosed |
| US-9540417-B2 | Compositions and methods for treating ischemia and ischemia-reperfusion injury | ISCHEMIX LLC (US) | 2017-01-10 | — | — | US | disclosed |
| US-20090285888-A1 | DERIVATIVES OF DIHYDROXYPHENYLALANINE | ELLNEUROXX LTD. (DE) | 2009-11-19 | — | — | US | disclosed |
| US-20090117346-A1 | PHOTOSENSITIVE MATERIAL FOR FORMING CONDUCTIVE FILM, CONDUCTIVE FILM, LIGHT TRANSMITTING ELECTROMAGNETIC WAVE SHIELDING FILM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2009-05-07 | — | — | US | disclosed |
| US-20090098480-A1 | PHOTOSENSITIVE MATERIAL FOR FORMING CONDUCTIVE FILM, CONDUCTIVE FILM, LIGHT TRANSMITTING ELECTROMAGNETIC WAVE SHIELDING FILM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090098481-A1 | PHOTOSENSITIVE MATERIAL FOR FORMING CONDUCTIVE FILM, CONDUCTIVE FILM, LIGHT TRANSMITTING ELECTROMAGNETIC WAVE SHIELDING FILM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| US-20090029125-A1 | PHOTOSENSITIVE MATERIAL FOR FORMING CONDUCTIVE FILM, CONDUCTIVE FILM, LIGHT TRANSMITTING ELECTROMAGNETIC WAVE SHIELDING FILM AND METHOD FOR MANUFACTURING THE SAME | FUJIFILM CORPORATION (JP) | 2009-01-29 | — | — | US | disclosed |
| CN-101208326-A | Derivate von dihydroxyphenylalanin | ELLNEUROXX LTD (DE) | 2008-06-25 | — | — | CN | disclosed |
| US-7320867-B2 | Linker compound, ligand, and producing method thereof | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-22 | — | — | US | disclosed |
| WO-2006021413-A1 | ALPHA-KETO CARBONYL CALPAIN INHIBITORS | SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) | 2006-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285888-A1 | DERIVATIVES OF DIHYDROXYPHENYLALANINE | HTT, NLN, SNCA | HSD17B10 1148/4885KMT2A 717/4885TARDBP 27/4885 |
| US-20130209551-A1 | PENTAPEPTIDE DERIVATIVES FOR PROMOTING HAIR GROWTH | NGLY1, CCNA1, TOE1 | HSD17B10 846/4885KMT2A 2749/4885TARDBP 4352/4885 |
| US-20170121360-A1 | APPARATUS AND METHOD FOR OBTAINING GLYCOGLYCEROLIPIDS AND GLYCOSPHINGOLIPIDS FROM LIPID PHASES | AGL, LIPA, MGLL | HSD17B10 348/4885KMT2A 2643/4885TARDBP 4871/4885 |
| US-10239906-B2 | Apparatus and method for obtaining glycoglycerolipids and glycosphingolipids from lipid phases | AGL, LIPA, MGLL | HSD17B10 348/4885KMT2A 2643/4885TARDBP 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.